Lyme Disease Diagnosis and Treatment Sample Clauses

Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, 3.24 - Office Visits, 3.20 - Infusion Therapy, and for prescription drugs, 3.28 and Pharmacy Benefits.
Sample 1Sample 2Sample 3See All (18)
AutoNDA by SimpleDocs
Lyme Disease Diagnosis and Treatment. This plan covers diagnostic testing and long-term antibiotic treatment of chronic Lyme disease in accordance with R.I. General Law § 27-20-48. To be covered, services must be ordered by your physician after evaluation of your symptoms, diagnostic test results, and response to treatment. Coverage for Lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational.
Sample 1Sample 2Sample 3See All (9)
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, refer to Sections 3.8 – Diagnostic Imaging, Lab, and Machine Tests, 3.24 - Office Visits, 3.21 Infusion Therapy, and 3.29 – Prescription Drugs.
Sample 1Sample 2Sample 3
Lyme Disease Diagnosis and Treatment. In accordance with Rhode Island General Law § 27-20-48, coverage is provided for diagnostic testing and long-term antibiotic treatment of chronic lyme disease when determined medically necessary. To qualify for payment, services must be ordered by your doctor after evaluation of your symptoms, diagnostic test results, and response to treatment. Benefit payment for lyme disease treatment will not be denied solely because such treatment may be characterized as unproven, experimental, or investigational. For coverage of specific services, see Section 3.8 - Diagnostic Imaging, Lab, and Machine Tests,
Sample 1

Related to Lyme Disease Diagnosis and Treatment

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Diagnosis For a condition to be considered a covered illness or disorder, copies of laboratory tests results, X-rays, or any other report or result of clinical examinations on which the diagnosis was based, are required as part of the positive diagnosis by a physician.

  • Hepatitis B Vaccine Where the Hospital identifies high risk areas where employees are exposed to Hepatitis B, the Hospital will provide, at no cost to the employees, a Hepatitis B vaccine.

  • Influenza Vaccine Upon recommendation of the Medical Officer of Health, all employees shall be required, on an annual basis to be vaccinated and or to take antiviral medication for influenza. If the costs of such medication are not covered by some other sources, the Employer will pay the cost for such medication. If the employee fails to take the required medication, she may be placed on an unpaid leave of absence during any influenza outbreak in the home until such time as the employee has been cleared by the public health or the Employer to return to the work environment. The only exception to this would be employees for whom taking the medication will result in the employee being physically ill to the extent that she cannot attend work. Upon written direction from the employee’s physician of such medical condition in consultation with the Employer’s physician, (if requested), the employee will be permitted to access their sick bank, if any, during any outbreak period. If there is a dispute between the physicians, the employee will be placed on unpaid leave. If the employee gets sick as a reaction to the drug and applies for WSIB the Employer will not oppose the application. If an employee is pregnant and her physician believes the pregnancy could be in jeopardy as a result of the influenza inoculation and/or the antiviral medication she shall be eligible for sick leave in circumstances where she is not allowed to attend at work as a result of an outbreak. This clause shall be interpreted in a manner consistent with the Ontario Human Rights Code.

Time is Money Join Law Insider Premium to draft better contracts faster.